Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: ANZU) is a Minnesota-based medical device company focused on fully implantable hearing solutions, including its flagship Acclaim Fully Implantable Cochlear Implant. The company became publicly traded in 2023 through a business combination with Anzu Special Acquisition Corp I, a blank-check company sponsored by Anzu Partners that completed its IPO in 2021. Operating in the hearing health and implantable medical device sector, Envoy Medical filed an 8-K with the SEC on May 18, 2026, disclosing a reportable corporate event. The company remains an active Nasdaq-listed issuer following the completion of its de-SPAC transaction. Visit SpacDesk and create a free account to access full filing history, sponsor data, and deal analytics for ANZU and hundreds of other SPAC transactions.